{"id":"https://openalex.org/W3021441237","doi":"https://doi.org/10.1182/blood.v130.suppl_1.1071.1071","title":"Emicizumab Prophylaxis in Adolescent/Adult Patients with Hemophilia A Previously Receiving Episodic or Prophylactic Bypassing Agent Treatment: Updated Analyses from the HAVEN 1 Study","display_name":"Emicizumab Prophylaxis in Adolescent/Adult Patients with Hemophilia A Previously Receiving Episodic or Prophylactic Bypassing Agent Treatment: Updated Analyses from the HAVEN 1 Study","publication_year":2017,"publication_date":"2017-12-07","ids":{"openalex":"https://openalex.org/W3021441237","doi":"https://doi.org/10.1182/blood.v130.suppl_1.1071.1071","mag":"3021441237"},"language":"en","primary_location":{"id":"mag:3021441237","doi":"https://doi.org/10.1182/blood.v130.suppl_1.1071.1071","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/1071/116325/Emicizumab-Prophylaxis-in-Adolescent-Adult","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033399787","display_name":"Maria Elisa Mancuso","orcid":"https://orcid.org/0000-0002-7113-4028","observed_orcids":["https://orcid.org/0000-0002-7113-4028"]},"institutions":[{"id":"https://openalex.org/I2803066834","display_name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","ror":"https://ror.org/016zn0y21","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I2803066834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Elisa Mancuso","raw_affiliation_strings":["Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico Milan Italy"],"raw_orcid":"https://orcid.org/0000-0002-7113-4028","affiliations":[{"raw_affiliation_string":"Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico Milan Italy","institution_ids":["https://openalex.org/I2803066834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000917771","display_name":"Michael U. Callaghan","orcid":"https://orcid.org/0000-0001-8742-0275","observed_orcids":["https://orcid.org/0000-0001-8742-0275"]},"institutions":[{"id":"https://openalex.org/I2800326109","display_name":"Detroit Medical Center","ror":"https://ror.org/05gehxw18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800326109"]},{"id":"https://openalex.org/I4210130818","display_name":"Children's Hospital of Michigan","ror":"https://ror.org/0429x9p85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800326109","https://openalex.org/I4210130818"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael U. Callaghan","raw_affiliation_strings":["Detroit Medical Center, Children's Hospital of Michigan, Detroit, MI"],"raw_orcid":"https://orcid.org/0000-0001-8742-0275","affiliations":[{"raw_affiliation_string":"Detroit Medical Center, Children's Hospital of Michigan, Detroit, MI","institution_ids":["https://openalex.org/I2800326109","https://openalex.org/I4210130818"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086373140","display_name":"Rebecca Kruse\u2010Jarres","orcid":"https://orcid.org/0000-0001-6547-5240","observed_orcids":["https://orcid.org/0000-0001-6547-5240"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I2799735646","display_name":"Bloodworks Northwest","ror":"https://ror.org/00ek9j693","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2799735646"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca Kruse\u2010Jarres","raw_affiliation_strings":["Washington Center for Bleeding Disorders at Bloodworks Northwest, University of Washington, Seattle, WA"],"raw_orcid":"https://orcid.org/0000-0001-6547-5240","affiliations":[{"raw_affiliation_string":"Washington Center for Bleeding Disorders at Bloodworks Northwest, University of Washington, Seattle, WA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I2799735646"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062598474","display_name":"Christine L. Kempton","orcid":"https://orcid.org/0000-0002-2391-2016","observed_orcids":["https://orcid.org/0000-0002-2391-2016"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine L. Kempton","raw_affiliation_strings":["Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA;"],"raw_orcid":"https://orcid.org/0000-0002-2391-2016","affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA;","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053509821","display_name":"Jin Xu","orcid":"https://orcid.org/0000-0002-9860-7796","observed_orcids":["https://orcid.org/0000-0002-9860-7796"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jin Xu","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA"],"raw_orcid":"https://orcid.org/0000-0002-9860-7796","affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066370748","display_name":"Olivier Catalani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Olivier Catalani","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Basel Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Basel Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086435750","display_name":"Elina Asikanius","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Elina Asikanius","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Basel Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Basel Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110579558","display_name":"Gallia G. Levy","orcid":"https://orcid.org/0009-0008-2051-2819","observed_orcids":["https://orcid.org/0009-0008-2051-2819"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gallia G. Levy","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017307924","display_name":"Midori Shima","orcid":"https://orcid.org/0000-0002-5922-7061","observed_orcids":["https://orcid.org/0000-0002-5922-7061"]},"institutions":[{"id":"https://openalex.org/I64926303","display_name":"Nara Medical University","ror":"https://ror.org/045ysha14","country_code":"JP","type":"education","lineage":["https://openalex.org/I64926303"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Midori Shima","raw_affiliation_strings":["Department of Pediatrics, Nara Medical University, Kashihara, Japan"],"raw_orcid":"https://orcid.org/0000-0002-5922-7061","affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Nara Medical University, Kashihara, Japan","institution_ids":["https://openalex.org/I64926303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004338432","display_name":"Guy A. Young","orcid":"https://orcid.org/0000-0001-6013-1254","observed_orcids":["https://orcid.org/0000-0001-6013-1254"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guy Young","raw_affiliation_strings":["University of Southern California Keck School of Medicine, Children's Hospital Los Angeles, Los Angeles, CA"],"raw_orcid":"https://orcid.org/0000-0001-6013-1254","affiliations":[{"raw_affiliation_string":"University of Southern California Keck School of Medicine, Children's Hospital Los Angeles, Los Angeles, CA","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I1336910626"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079861916","display_name":"Johannes Oldenburg","orcid":"https://orcid.org/0000-0002-1585-4100","observed_orcids":["https://orcid.org/0000-0002-1585-4100","https://orcid.org/0000-0003-3038-2145"]},"institutions":[{"id":"https://openalex.org/I2799391451","display_name":"University Hospital Bonn","ror":"https://ror.org/01xnwqx93","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799391451"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Johannes Oldenburg","raw_affiliation_strings":["Universit\u00e4tsklinikum Bonn; Bonn; Germany"],"raw_orcid":"https://orcid.org/0000-0002-1585-4100","affiliations":[{"raw_affiliation_string":"Universit\u00e4tsklinikum Bonn; Bonn; Germany","institution_ids":["https://openalex.org/I2799391451"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.9003,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.87054503,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"130","issue":null,"first_page":"1071","last_page":"1071"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/emicizumab","display_name":"emicizumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/hemophilia-a","display_name":"hemophilia A","score":0.9900000095367432},{"id":"https://openalex.org/keywords/factor-viii-inhibitors","display_name":"factor VIII inhibitors","score":0.8939999938011169},{"id":"https://openalex.org/keywords/prophylaxis","display_name":"prophylaxis","score":0.7239999771118164},{"id":"https://openalex.org/keywords/annualized-bleeding-rate","display_name":"annualized bleeding rate","score":0.9049999713897705},{"id":"https://openalex.org/keywords/bypassing-agents","display_name":"bypassing agents","score":0.8579999804496765},{"id":"https://openalex.org/keywords/factor-viii-replacement","display_name":"factor VIII replacement","score":0.3230000138282776},{"id":"https://openalex.org/keywords/factor-ix","display_name":"factor IX","score":0.3659999966621399},{"id":"https://openalex.org/keywords/factor-x","display_name":"factor X","score":0.8569999933242798},{"id":"https://openalex.org/keywords/bleeding-prevention","display_name":"bleeding prevention","score":0.531000018119812},{"id":"https://openalex.org/keywords/adolescents-and-adults","display_name":"adolescents and adults","score":0.6639999747276306},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.7319999933242798},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.5139999985694885},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.492000013589859}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.717884361743927},{"id":"https://openalex.org/C3020646304","wikidata":"https://www.wikidata.org/wiki/Q1773974","display_name":"Prophylactic treatment","level":2,"score":0.479302316904068},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3948807716369629},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3894558250904083},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3089868724346161}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3021441237","doi":"https://doi.org/10.1182/blood.v130.suppl_1.1071.1071","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/1071/116325/Emicizumab-Prophylaxis-in-Adolescent-Adult","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6499999761581421,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2921022486","https://openalex.org/W3097601655","https://openalex.org/W3115183047","https://openalex.org/W2980900975","https://openalex.org/W2784786061","https://openalex.org/W6939425158","https://openalex.org/W2936143155","https://openalex.org/W2888898681","https://openalex.org/W7219443355","https://openalex.org/W4220844694"],"abstract_inverted_index":{"Introduction":[0],"Emicizumab":[2,112,164,207,331],"is":[3],"a":[4,72,84,91,94,167,210,225,443,497],"bispecific":[5],"humanized":[6],"monoclonal":[7],"antibody":[8],"in":[9,46,135,139,156,171,186,247,293,301,352,364,447],"development":[10],"for":[11,118,279,377,380,391,482,503],"the":[12,47,140,157,187,221,233,338,356,381,400,429,460,480,504],"management":[13,505],"of":[14,93,153,200,214,220,227,270,307,373,383,449,463,501,506,556,567,578,603,619,640,653,670,681,730,767,782,822,837,850,870,883,896,911,924,939,954,967,988,1003],"patients":[15],"(pts)":[16],"with":[17,41,256,272,327,370,411,453,508],"hemophilia":[18],"A":[19],"(PwHA)":[20],"with/without":[21],"inhibitors.":[22,509],"Administered":[23],"subcutaneously,":[24],"emicizumab":[25,51,154,201,239,257,308,317,387,395,438,466,487],"restores":[26],"missing":[27],"FVIIIa":[28],"function":[29],"by":[30,63,83,122,399],"bridging":[31],"FIXa":[32],"and":[33,102,252,263,276,282,286,473,492,495,859,980],"FX":[34],"to":[35,109,238,321,333,402,441,468,489],"facilitate":[36],"effective":[37],"hemostasis.":[38],"In":[39,182],"PwHA":[40,507],"inhibitors":[42],"aged":[43],"\u226512":[44],"yr":[45],"HAVEN":[48,69,365,431],"1":[49,70,432],"study,":[50],"prophylaxis":[52,55,165,208,258,309,312,396,439,488],"vs":[53,175,310],"no":[54,311,345,408],"reduced":[56],"annualized":[57],"bleeding":[58],"rate":[59],"(ABR;":[60],"treated":[61,245,274,283,450],"bleeds)":[62,174],"87%":[64,215],"(P":[65],"Methods":[67],"was":[71,81,113,160,203,240,259,397,418],"randomized,":[73],"multicenter,":[74],"open-label,":[75],"phase":[76],"3":[77,116],"study":[78,110],"(NCT0262232),":[79],"which":[80,367],"preceded":[82],"NIS":[85],"(Fig":[86],"1).":[87],"Eligibility":[88],"criteria":[89],"included":[90,138,185],"history":[92],"high":[95],"FVIII":[96],"inhibitor":[97],"titer":[98],"(\u22655":[99],"Bethesda":[100],"U/mL),":[101],"episodic":[103,145,177,455],"or":[104,456,558,569,580,605,621,642,655,672,683,694,732,769,784,824,839,852,872,885,898,913,926,941,956,969,990,1005],"prophylactic":[105,192,457],"BPA":[106,193,392,458],"treatment":[107,353,382,491],"prior":[108,144,176,191,454],"entry.":[111],"administered":[114,486],"at":[115,324],"mg/kg/wk":[117,124],"4":[119],"wk":[120,306],"followed":[121],"1.5":[123],"thereafter.":[125],"Results":[127],"At":[129],"data":[130,223,435,478],"cutoff":[131],"(April":[132],"21,":[133],"2017),":[134],"24":[136,183,305],"pts":[137,184,229,271,410],"intra-individual":[141,188,433],"comparisons":[142,189],"receiving":[143,190],"BPAs":[146,178],"(Arm":[147,194],"A,":[148,249],"n=24),":[149,196],"median":[150,197],"(range)":[151,198,236],"period":[152,199],"exposure":[155,202,237],"updated":[158,222,430],"analyses":[159],"56.29":[161],"(0.1-74.3)":[162,242],"wk.":[163,206,243],"showed":[166,209],"clinically":[168,211,444],"meaningful":[169,212],"reduction":[170,213,446],"ABR":[172,255,471],"(treated":[173],"(95%;":[179],"P":[180],"C,":[195],"55.6":[204],"(24.1-70.7)":[205],"(p":[216],"Overall,":[218],"as":[219],"cutoff,":[224],"total":[226],"112":[228],"were":[230,313,368,407],"enrolled":[231],"into":[232],"study.":[234],"Median":[235],"40.9":[241],"For":[244],"bleeds":[246,289,385,451],"Arms":[248],"B,":[250],"C":[251],"D,":[253],"respectively,":[254],"2.4,":[260],"1.0,":[261],"3.6":[262],"2.9":[264],"(Table":[265],"2).":[266],"The":[267,296],"corresponding":[268],"proportion":[269],"zero":[273],"bleeds,":[275,281],"bleed-related":[277],"endpoints":[278],"all":[280],"spontaneous,":[284],"joint":[285,288],"target":[287],"are":[290],"also":[291],"shown":[292],"Table":[294],"2.":[295],"previously":[297,358],"reported":[298,359],"marked":[299],"improvements":[300],"HRQoL/health":[302],"status":[303],"after":[304],"sustained.":[314],"Mean":[315],"trough":[316],"plasma":[318],"concentrations":[319],"continued":[320,467],"be":[322,334,474],"sustained":[323],"~50":[325],"\u00b5g/mL":[326],"longer":[328,427],"follow-up.":[329],"continues":[332,440],"well":[335,475],"tolerated.":[336,476],"Since":[337],"previous":[339],"report":[340],"(Oldenburg":[341],"et":[342],"al.":[343],"2017)":[344],"new":[346,499],"adverse":[347],"events":[348,363,414],"(AEs)":[349],"have":[350],"resulted":[351],"discontinuation.":[354],"During":[355],"emerging,":[357],"thrombotic":[360],"microangiopathy":[361],"(TMA)/thrombotic":[362],"1,":[366],"associated":[369],"cumulative":[371],"doses":[372],"aPCC":[374],">100":[375],"U/kg":[376],"\u226524":[378],"hr":[379],"breakthrough":[384],"during":[386,394],"prophylaxis,":[388],"dosing":[389],"guidance":[390,417],"use":[393],"provided":[398],"sponsor":[401],"mitigate":[403],"further":[404],"risk;":[405],"there":[406],"additional":[409],"such":[412],"TMA/thrombotic":[413],"when":[415],"this":[416],"followed.":[419],"Conclusion":[421],"With":[423],"nearly":[424],"6":[425],"months9":[426],"follow-up,":[428],"comparison":[434],"show":[436],"that":[437],"demonstrate":[442],"significant":[445],"risk":[448],"compared":[452],"treatment,":[459],"current":[461],"standard":[462,500],"care.":[464],"Additionally,":[465],"maintain":[469],"low":[470],"overall":[472],"These":[477],"support":[479],"potential":[481,498],"once":[483],"weekly,":[484],"subcutaneously":[485],"reduce":[490],"disease":[493],"burden,":[494],"provide":[496],"care":[502],"Disclosures":[511],"Mancuso:":[513],"Pfizer:":[514,702,755,875],"Consultancy,":[515,520,525,530,535,539,700,703,708,713,716,719,760,775,794,815,830,843,863,876,889,904,917,932,947,960,975,996],"Speakers":[516,521,526,531,536,540,543,548,583,587,645,661],"Bureau;":[517,522,527,532,537,541,549,584,588,646,662],"Sobi/Biogen":[518],"Idec:":[519],"Novo":[523,585,807],"Nordisk:":[524,586,808],"CSL":[528,663,698,810],"Behring:":[529,664,699,811],"Bayer":[533,589],"Healthcare:":[534],"Kedrion:":[538],"Baxalta/Shire:":[542],"Bureau.":[544],"Callaghan:":[545],"Roche;":[546,593],"Shire:":[547,572,594,712],"Grifols:":[550,715,931],"Membership":[551,562,573,598,614,635,648,665,676,725,762,777,817,832,845,865,878,891,906,919,934,949,962,983,998],"on":[552,563,574,599,615,636,649,666,677,726,763,778,818,833,846,866,879,892,907,920,935,950,963,984,999],"an":[553,564,575,600,616,637,650,667,678,727,764,779,819,834,847,867,880,893,908,921,936,951,964,985,1000],"entity9s":[554,565,576,601,617,638,651,668,679,728,765,780,820,835,848,868,881,894,909,922,937,952,965,986,1001],"Board":[555,566,577,602,618,639,652,669,680,729,766,781,821,836,849,869,882,895,910,923,938,953,966,987,1002],"Directors":[557,568,579,604,620,641,654,671,682,731,768,783,823,838,851,871,884,897,912,925,940,955,968,989,1004],"advisory":[559,570,581,606,622,643,656,673,684,733,770,785,825,840,853,873,886,899,914,927,942,957,970,991,1006],"committees;":[560,571,623,674,685,841,874,887,915,958],"Octapharma:":[561,888],"committees,":[582,607,644,657,771,786,826,854,900,928,943,971,992,1007],"HealthCare;":[590],"Pfizer":[591,596],"Inc.;":[592],"Consultancy;":[595,809],"Inc.:":[597,752],"Other:":[608,627,631,658,689,855],"Site":[609,628,632,659],"PI,":[610,660],"Research":[611,705,710,757,772,787,791,800,804,827,860,901,929,944,972,981,993,1008],"Funding;":[612,706,711,758,773,788,792,801,828,861,902,930,945,973,994],"Biogen:":[613,793,946],"Global":[624],"Blood":[625],"Therapeutics:":[626],"PI;":[629,633],"Sancillio:":[630],"Baxalta:":[634,721,759,842],"Roche/Genentech:":[647,707],"Bayer:":[675,718,802,974],"Alnylam":[686],"Pharmaceuticals,":[687],"Inc:":[688],"Owns":[690],"stock,":[691],"stock":[692],"options,":[693],"bonds":[695],".":[696],"Kruse-Jarres:":[697],"Honoraria;":[701,714,717,720,795,797],"Honoraria,":[704,709,756,761,776,790,799,803,816,831,844,864,877,890,905,918,933,948,961,976,997],"Honoraria.":[722,812],"Kempton:":[723],"Genentech:":[724,736],"committees.":[734],"Xu:":[735],"Employment.":[737,743,749,753],"Catalani:":[738],"F.":[739,745],"Hoffmann-La":[740,746],"Roche":[741,747],"Ltd:":[742,748],"Asikanius:":[744],"Levy:":[750],"Genentech,":[751],"Shima:":[754],"Chugai:":[774,903],"CSL:":[789,916],"Kaketsuken:":[796],"Novo:":[798,959],"Funding.":[805,1009],"Young:":[806],"Oldenburg:":[813],"Biotest:":[814],"Roche:":[829],"Investigator":[856,977],"Clinical":[857,978],"Studies":[858,979],"Sobi:":[862],"Funding,":[982],"Baxter:":[995]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-05-13T00:00:00"}